English
|
中文
Home
About Anbio
Return
Company Introduction
Company Qualification
Technical Cooperation
Products
Return
COVID-19
Return
Rapid screening diagnosis
Confirmation diagnosis
Differential diagnosis
Vaccine effectiveness series
Mutant strain Virus diagnosis
Immunofluorescence
Return
Cardiovascular
Inflammation
Apoplexy
Diabetes
Renal Function
Bone Calcium
Gastric Function
Thyroid Function
Sex Hormone
Tumor Markers
Allergy
Hair Trace Drugs
Colloidal Gold
Nucleic Aicd Assay
Detecting Instrument
Solutions
Return
COVID-19
Hair Drug Detection
Chest Pain Center
Stroke Center
Endocrine Clinic
Company News
Return
Company news
Industry trends
Recruitment
Download
Return
English
German
Contact Us
Operation video
Home
About Anbio
Return
Company Introduction
Company Qualification
Technical Cooperation
Products
Return
COVID-19
Return
Rapid screening diagnosis
Confirmation diagnosis
Differential diagnosis
Vaccine effectiveness series
Mutant strain Virus diagnosis
Immunofluorescence
Return
Cardiovascular
Inflammation
Apoplexy
Diabetes
Renal Function
Bone Calcium
Gastric Function
Thyroid Function
Sex Hormone
Tumor Markers
Allergy
Hair Trace Drugs
Colloidal Gold
Nucleic Aicd Assay
Detecting Instrument
Solutions
Return
COVID-19
Hair Drug Detection
Chest Pain Center
Stroke Center
Endocrine Clinic
Company News
Return
Company news
Industry trends
Recruitment
Download
Return
English
German
Contact Us
Operation video
English
|
中文
Anbio COVID-19 Self-Testing(Nasal Swab) Obtained German Emergency Use Authorization
Column:Company news
Time:2021-07-07
Previous:
Good News:The latest 6 products have obtained CE EU market access qualification
Next:
Anbio COVID-19 Self-Testing(Saliva) Obtained German Emergency Use Authorization